Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Farmers Insurance
Johnson and Johnson

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204949

« Back to Dashboard

NDA 204949 describes AZACITIDINE, which is a drug marketed by Actavis Llc, Cipla Ltd, Dr Reddys Labs Ltd, Mylan Institutional, Natco Pharma Ltd, and Shilpa Medicare, and is included in six NDAs. It is available from ten suppliers. Additional details are available on the AZACITIDINE profile page.

The generic ingredient in AZACITIDINE is azacitidine. There are fourteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the azacitidine profile page.
Summary for 204949
Applicant:Mylan Institutional
Formulation / Manufacturing:see details
Pharmacology for NDA: 204949
Medical Subject Heading (MeSH) Categories for 204949
Suppliers and Packaging for NDA: 204949
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 204949 ANDA Mylan Institutional LLC 67457-254 N 67457-254-30

Profile for product number 001

Approval Date:Apr 28, 2016TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.